Home HCP ALL
Xatmep: The first and only FDA-approved methotrexate oral solution for the treatment of ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) in pediatric patients.
- Assured efficacy delivered with consistent potency.1
- The first and only FDA-approved methotrexate oral solution for ALL.
- Oral solution provides consistent stability when stored as directed.2
- No compounding or crushing tablets necessary.
- No methotrexate injections necessary.
- Body surface area-based dosing.